packageTremelimumab

tremelimumab

Extends from Pharmacolibrary.Interfaces.PartialSubstance (Identity and physicochemical constants of one drug (Drugs.Substances)).

Information

Tremelimumab is a monoclonal antibody used as an anticancer medicine, notably for liver cancer and non-small-cell lung cancer. It is authorised in the European Union and is also being studied for other uses.

Summary written by glm-5.3-flash from Wikidata Q7838098 and the WHO ATC classification and the EMA medicines list; not checked by a person.

name:tremelimumab
ATC codes:L01FX20
DrugBank:DB11771
Wikidata:Q7838098
molar mass:149000 g/mol (Drugs.Common 25.09, not verified)

Parameters

TypeNameDefaultDescription
Stringname (from PartialSubstance)""INN / common name
String[:]atcCodes (from PartialSubstance)fill("", 0)all WHO ATC codes of the drug
StringdrugbankId (from PartialSubstance)""e.g. DB00758
StringpubchemCid (from PartialSubstance)""PubChem compound id
StringchebiId (from PartialSubstance)""ChEBI id (number)
StringwikidataId (from PartialSubstance)""e.g. Q410238
Stringformula (from PartialSubstance)""molecular formula
Modelica.Units.SI.MolarMassM (from PartialSubstance)0molar mass; 0 = unknown
ReallogP (from PartialSubstance)Modelica.Constants.infoctanol-water partition coefficient (log10); inf = unknown